Tyra Biosciences Inc. Common Stock (TYRA)
Stock · NASDAQ · Health Care
$24.94as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Resistance level
$30.08
Industry
Biotechnology: Pharmaceutical Preparations
Fundamentals
- Market cap
- $1.61B
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
Tyra Biosciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- TYRATyra Biosciences Inc. Common Stock$24.94▼ 4.55%Market cap $1.61BP/E —
- MRVIMaravai LifeSciences Holdings Inc. Class A Common Stock$7.67▼ 8.42%Market cap $1.61BP/E —$2.29$9.42
- AAPGAscentage Pharma Group International American Depository Shares$18.28▼ 2.16%Market cap $1.60BP/E —$30$91.5
- TRAXFirst Tracks Biotherapeutics Inc. Ordinary Shares$41.77▼ 6.64%Market cap $1.58BP/E —$14.72$49.91
- INVAInnoviva Inc. Common Stock$20.97▲ 0.05%Market cap $1.56BP/E 4.21$16.52$25.15
- LKFTLakefront Biotherapeutics American Depositary Shares$28.86▼ 1.97%Market cap $1.72BP/E 3.29$22.32$27.12
- HROWHarrow Inc. Common Stock$37.23▼ 3.40%Market cap $1.49BP/E —$28.54$54.85
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TYRA Tyra Biosciences Inc. Common Stock | $1.61B | — | $24.94 | ▼ 4.55% | |
| MRVI Maravai LifeSciences Holdings Inc. Class A Common Stock | $1.61B | — | $7.67 | ▼ 8.42% | $2.29$9.42 |
| AAPG Ascentage Pharma Group International American Depository Shares | $1.60B | — | $18.28 | ▼ 2.16% | $30$91.5 |
| TRAX First Tracks Biotherapeutics Inc. Ordinary Shares | $1.58B | — | $41.77 | ▼ 6.64% | $14.72$49.91 |
| INVA Innoviva Inc. Common Stock | $1.56B | 4.21 | $20.97 | ▲ 0.05% | $16.52$25.15 |
| LKFT Lakefront Biotherapeutics American Depositary Shares | $1.72B | 3.29 | $28.86 | ▼ 1.97% | $22.32$27.12 |
| HROW Harrow Inc. Common Stock | $1.49B | — | $37.23 | ▼ 3.40% | $28.54$54.85 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Tyra Biosciences: SURF302 Is A Worthwhile Binary BetSeekingAlpha · 8/10/2026
- Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent HighlightsYahoo · 8/4/2026
- Tyra Biosciences Q2 EPS $(0.69) Misses $(0.65) EstimateBenzinga · 8/4/2026
Insider Activity
Insider Actions →Acquired
647.8K
Disposed
0
- Verjee Rehan · May 28, 2026 · Grant13.2K
- Rothenberg Stephen Michael · May 28, 2026 · Grant13.2K
- Jake Simson · May 28, 2026 · Grant13.2K
- Susan Moran · May 28, 2026 · Grant13.2K
- Adele M. Gulfo · May 28, 2026 · Grant13.2K
- RA Capital Healthcare Fund LP · May 28, 2026 · Grant13.2K
- Robert J. More · May 28, 2026 · Grant13.2K
- Warner Douglas J · May 5, 2026 · Grant85.0K
- Warner Douglas J · May 5, 2026 · Grant25.0K
- Rueb Yuliya · May 5, 2026 · Grant28.0K
- Rueb Yuliya · May 5, 2026 · Grant8.3K
- Ashar Bhavesh · May 5, 2026 · Grant50.3K
- Ashar Bhavesh · May 5, 2026 · Grant15.0K
- Harris Todd · May 5, 2026 · Grant265.0K
- Harris Todd · May 5, 2026 · Grant79.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 65.92M
- Total value held
- $2.48B
- Institutional holders
- 157
Top holders this quarter
- Unknown12.20M
- Unknown7.75M
- Unknown4.06M
- Unknown3.89M
- Unknown3.82M
- Unknown3.58M
- Unknown3.25M
- Unknown2.48M
- Unknown2.22M
- Unknown2.05M
See the full, filterable feed with live charts on the MarketWall dashboard.